Dana Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.81M | Buy |
75,072
+5,196
| +7% | +$136K | 0.05% | 352 |
|
|
2026
Q1 | $1.96M | Buy |
69,876
+2,716
| +4% | +$72.3K | 0.06% | 314 |
|
|
2025
Q4 | $1.67M | Buy |
67,160
+349
| +0.5% | +$8.8K | 0.05% | 333 |
|
|
2025
Q3 | $1.7M | Sell |
66,811
-36,261
| -35% | -$895K | 0.05% | 325 |
|
|
2025
Q2 | $2.5M | Buy |
103,072
+4,180
| +4% | +$97.5K | 0.08% | 252 |
|
|
2025
Q1 | $2.51M | Sell |
98,892
-870
| -0.9% | -$22.8K | 0.09% | 247 |
|
|
2024
Q4 | $2.65M | Sell |
99,762
-7,705
| -7% | -$209K | 0.09% | 252 |
|
|
2024
Q3 | $3.11M | Buy |
107,467
+7,286
| +7% | +$213K | 0.1% | 229 |
|
|
2024
Q2 | $2.8M | Buy |
100,181
+8,771
| +10% | +$241K | 0.09% | 236 |
|
|
2024
Q1 | $2.54M | Buy |
91,410
+879
| +1% | +$24.4K | 0.08% | 256 |
|
|
2023
Q4 | $2.61M | Sell |
90,531
-2,352
| -3% | -$71.1K | 0.13% | 137 |
|
|
2023
Q3 | $3.08M | Buy |
92,883
+3,751
| +4% | +$133K | 0.16% | 116 |
|
|
2023
Q2 | $3.27M | Sell |
89,132
-402
| -0.4% | -$15.6K | 0.16% | 107 |
|
|
2023
Q1 | $3.65M | Sell |
89,534
-904
| -1% | -$39K | 0.19% | 104 |
|
|
2022
Q4 | $4.63M | Sell |
90,438
-1,815
| -2% | -$87K | 0.24% | 92 |
|
|
2022
Q3 | $4.04M | Sell |
92,253
-37,399
| -29% | -$1.82M | 0.23% | 93 |
|
|
2022
Q2 | $6.8M | Buy |
129,652
+15,535
| +14% | +$792K | 0.34% | 79 |
|
|
2022
Q1 | $5.91M | Sell |
114,117
-55,928
| -33% | -$2.9M | 0.27% | 78 |
|
|
2021
Q4 | $10M | Buy |
170,045
+100,445
| +144% | +$4.98M | 0.43% | 67 |
|
|
2021
Q3 | $2.99M | Sell |
69,600
-9,971
| -13% | -$442K | 0.14% | 105 |
|
|
2021
Q2 | $3.12M | Buy |
79,571
+14,522
| +22% | +$565K | 0.14% | 103 |
|
|
2021
Q1 | $2.36M | Buy |
65,049
+10,043
| +18% | +$357K | 0.11% | 118 |
|
|
2020
Q4 | $2.02M | Buy |
55,006
+9,512
| +21% | +$349K | 0.1% | 131 |
|
|
2020
Q3 | $1.58M | Buy |
45,494
+1,262
| +3% | +$44.2K | 0.09% | 137 |
|
|
2020
Q2 | $1.37M | Sell |
44,232
-246
| -0.6% | -$8.36K | 0.07% | 164 |
|
|
2020
Q1 | $1.38M | Sell |
44,478
-16,987
| -28% | -$579K | 0.08% | 134 |
|
|
2019
Q4 | $2.29M | Buy |
61,465
+3,091
| +5% | +$110K | 0.11% | 113 |
|
|
2019
Q3 | $1.99M | Sell |
58,374
-1,735
| -3% | -$63.1K | 0.1% | 132 |
|
|
2019
Q2 | $2.47M | Sell |
60,109
-365,764
| -86% | -$14.5M | 0.12% | 112 |
|
|
2019
Q1 | $17.2M | Sell |
425,873
-82,784
| -16% | -$3.32M | 0.81% | 47 |
|
|
2018
Q4 | $21.1M | Sell |
508,657
-142,531
| -22% | -$5.92M | 1.07% | 36 |
|
|
2018
Q3 | $27.2M | Sell |
651,188
-31,778
| -5% | -$1.22M | 1.11% | 36 |
|
|
2018
Q2 | $23.5M | Buy |
682,966
+37,980
| +6% | +$1.3M | 1.03% | 39 |
|
|
2018
Q1 | $21.7M | Buy |
644,986
+2,809
| +0.4% | +$96.6K | 0.98% | 43 |
|
|
2017
Q4 | $22.1M | Buy |
642,177
+354
| +0.1% | +$12.1K | 0.96% | 45 |
|
|
2017
Q3 | $21.7M | Buy |
641,823
+29,896
| +5% | +$961K | 1% | 43 |
|
|
2017
Q2 | $19.5M | Sell |
611,927
-49,317
| -7% | -$1.56M | 0.92% | 44 |
|
|
2017
Q1 | $21.5M | Sell |
661,244
-39,726
| -6% | -$1.25M | 1% | 40 |
|
|
2016
Q4 | $21.6M | Sell |
700,970
-45,397
| -6% | -$1.39M | 1.02% | 37 |
|
|
2016
Q3 | $24M | Sell |
746,367
-5,504
| -0.7% | -$184K | 1.15% | 38 |
|
|
2016
Q2 | $25.1M | Buy |
751,871
+36,616
| +5% | +$1.17M | 1.12% | 38 |
|
|
2016
Q1 | $20.1M | Buy |
715,255
+696,930
| +3,803% | +$19.9M | 0.91% | 45 |
|
|
2015
Q4 | $17.4M | Sell |
18,325
-474,727
| -96% | -$14.9M | 0.84% | 49 |
|
|
2015
Q3 | $14.7M | Buy |
493,052
+393,528
| +395% | +$12.6M | 0.69% | 54 |
|
|
2015
Q2 | $3.17M | Buy |
99,524
+8,248
| +9% | +$269K | 0.15% | 116 |
|
|
2015
Q1 | $3.01M | Sell |
91,276
-11,723
| -11% | -$373K | 0.15% | 114 |
|
|
2014
Q4 | $3.04M | Buy |
102,999
+17,195
| +20% | +$493K | 0.12% | 115 |
|
|
2014
Q3 | $2.41M | Buy |
85,804
+2,714
| +3% | +$76.2K | 0.14% | 125 |
|
|
2014
Q2 | $2.34M | Buy |
83,090
+10,596
| +15% | +$302K | 0.14% | 121 |
|
|
2014
Q1 | $2.21M | Buy |
72,494
+159
| +0.2% | +$4.74K | 0.14% | 122 |
|
|
2013
Q4 | $2.1M | Buy |
+72,335
| New | +$2.11M | 0.14% | 125 |
|
Other funds holding PFE
Dana Investment Advisors's PFE Position: Q2 2026 in Review
Dana Investment Advisors increased its Pfizer (PFE) stake by 7.4% in Q2 2026, buying an estimated $136K and bringing the position to 75,072 shares worth $1.81M. The position accounts for 0.05% of the portfolio, ranked #352.
Dana Investment Advisors first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $27.2M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Dana Investment Advisors held 75,072 shares of Pfizer worth $1.81M as of Q2 2026.
- Dana Investment Advisors bought 5,196 Pfizer shares in Q2 2026, an estimated $136K.
- Pfizer made up 0.05% of Dana Investment Advisors's portfolio in Q2 2026, its #352 holding.
- Dana Investment Advisors first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
- Dana Investment Advisors's Pfizer position peaked at $27.2M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.